Physician
Galen Medical Group, PC
Galen Medical Group, PC was paid $10.23M by Medicaid between Jan 2018 and Dec 2024, across 116 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 21% of everything it billed.
33Billing provider infoGALEN MEDICAL GROUP, PC
HIXSON, TN 37343
HIXSON, TN 37343
33aNPI1346250057assigned 08/08/2006
33bProvider typeAllergy & Immunology Physician
28Total paid$10.23M
24GClaims387,127
24DCodes billed116
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Allergy & Immunology Physician providers in Tennessee
Rank by total paid#1 of 27
Median peer was paid$48K
This provider vs. median211×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 44,148 | $1.04M | |
| 2019 | 54,757 | $1.26M | |
| 2020 | 46,799 | $1.21M | |
| 2021 | 80,974 | $2.17M | |
| 2022 | 65,814 | $1.83M | |
| 2023 | 56,170 | $1.55M | |
| 2024incomplete | 38,465 | $1.17M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 21% | 62,460 | 55,262 | $2.18M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 11% | 23,406 | 20,444 | $1.17M |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | 7.7% | 5,730 | 5,139 | $793K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 7.2% | 15,985 | 13,420 | $741K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 6.8% | 18,743 | 16,662 | $698K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 6.5% | 10,405 | 9,614 | $670K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 4.9% | 7,956 | 7,246 | $498K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 4.3% | 8,640 | 6,777 | $444K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 4.0% | 7,109 | 5,250 | $407K |
| 95117 | 3.9% | 43,740 | 20,530 | $400K | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | 3.5% | 3,708 | 2,992 | $356K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 2.3% | 3,448 | 2,856 | $233K |
104 more codes
| 92587 | 2.2% | 5,204 | $224K | |
| 94375 | 1.0% | 5,381 | $105K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.0% | 7,842 | $102K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 7,224 | $95K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 1,140 | $91K |
| 95024 | <1% | 1,363 | $85K | |
| 99173 | <1% | 10,489 | $85K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 6,003 | $84K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 668 | $83K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 4,280 | $74K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 8,917 | $72K |
| 96161 | <1% | 3,146 | $61K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 3,482 | $57K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 5,369 | $51K |
| 99174 | <1% | 4,855 | $45K | |
| 90677 | <1% | 551 | $32K | |
| 95115 | <1% | 3,733 | $27K | |
| 96160 | <1% | 2,207 | $26K | |
| 81003 | <1% | 10,655 | $23K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 422 | $22K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 696 | $21K |
| 96127 | <1% | 4,150 | $16K | |
| 90670 | <1% | 4,683 | $14K | |
| 92551 | <1% | 1,742 | $11K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 4,414 | $10K |
| 0240U | <1% | 73 | $9K | |
| 83655 | <1% | 575 | $9K | |
| 36416 | <1% | 2,931 | $8K | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 476 | $7K |
| 90698 | <1% | 3,481 | $6K | |
| 95012 | <1% | 1,744 | $6K | |
| 94060 | <1% | 177 | $6K | |
| 98966 | <1% | 212 | $6K | |
| 90461 | <1% | 8,810 | $5K | |
| 90656 | <1% | 314 | $5K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 80 | $4K |
| 90680 | <1% | 2,336 | $4K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 177 | $4K |
| 90619 | <1% | 70 | $4K | |
| 90474 | <1% | 468 | $4K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 70 | $3K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 80 | $3K |
| 90651 | <1% | 284 | $3K | |
| 90688 | <1% | 2,061 | $3K | |
| 99384 | <1% | 35 | $2K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 46 | $2K |
| 90686 | <1% | 2,308 | $2K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 66 | $2K |
| 90716 | <1% | 581 | $1K | |
| 90700 | <1% | 3,139 | $1K | |
| 99383 | <1% | 13 | $1K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 17 | $1K |
| 90707 | <1% | 587 | $976.18 | |
| 90713 | <1% | 1,777 | $932.50 | |
| 90633 | <1% | 961 | $931.72 | |
| 90473 | <1% | 100 | $823.13 | |
| 90734 | <1% | 125 | $818.60 | |
| 90744 | <1% | 1,299 | $701.51 | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 18 | $643.04 |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 15 | $637.64 |
| 87428 | <1% | 12 | $635.90 | |
| 99460 | <1% | 12 | $562.07 | |
| 92558 | <1% | 77 | $535.21 | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 18 | $524.48 |
| 88720 | <1% | 119 | $516.27 | |
| 82962 | <1% | 569 | $466.66 | |
| 80061 | Lipid panel | <1% | 68 | $446.60 |
| 81025 | <1% | 85 | $421.64 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 578 | $265.17 |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 32 | $264.86 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 16 | $262.78 |
| 90620 | <1% | 13 | $259.78 | |
| 95251 | <1% | 34 | $222.25 | |
| 90648 | <1% | 1,807 | $216.37 | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 12 | $186.94 |
| 87807 | <1% | 13 | $166.80 | |
| 87420 | <1% | 258 | $156.45 | |
| 94760 | <1% | 2,089 | $122.02 | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 17 | $114.58 |
| 92250 | <1% | 18 | $108.27 | |
| 91200 | <1% | 65 | $99.05 | |
| 90715 | <1% | 35 | $54.64 | |
| 87210 | <1% | 15 | $46.71 | |
| 84439 | <1% | 23 | $44.88 | |
| 90687 | <1% | 506 | $43.34 | |
| 90674 | <1% | 109 | $36.87 | |
| 76937 | <1% | 36 | $35.78 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 132 | $35.49 |
| 90672 | <1% | 43 | $28.23 | |
| 3008F | 0% | 23,248 | $0.00 | |
| 99070 | 0% | 52 | $0.00 | |
| 80050 | General health panel | 0% | 18 | $0.00 |
| J8540 | Dexamethasone, oral, 0.25 mg | 0% | 19 | $0.00 |
| 87081 | 0% | 39 | $0.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 0% | 21 | $0.00 |
| 0500F | 0% | 78 | $0.00 | |
| 3044F | 0% | 21 | $0.00 | |
| 4274F | 0% | 332 | $0.00 | |
| 90685 | 0% | 68 | $0.00 | |
| 99001 | 0% | 883 | $0.00 | |
| 3078F | 0% | 20 | $0.00 | |
| 90710 | 0% | 13 | $0.00 | |
| 2028F | 0% | 38 | $0.00 | |
| 90661 | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWILEY, BENJAMIN (MEDICAL DIRECTOR)